Address5101 Cass Ave., Detroit, MI 48202
Office: 469 Chem
Lab: 460 Chem
Laboratory Web Site
• Chemical tools to track how glycans change spatiotemporally during cell metabolism and signaling
• Biochemical studies to discover and predict functional effects of protein glycosylation
• Medicinal chemistry to inhibit metabolic risk factors in tumorigenic pathways
All cells use sugar, but a consequence of unbalanced sugar usage is disease through hexosamine sugar signaling pathways including glucosamines. To precisely define the roles of hexosamine sugar-driven effects, the Fehl Group designs chemical tools sensitive for live-cell applications, for example our light-controlled photosugars and our cell compartment-specific "GlycoID" labeling strategy. We apply chemical biology tools at the interface of metabolism disease and cancer pathways to discover new roles for glucose-driven events in cells and disease. A key target area is determining the mechanisms and potential treatment strategies for cancers that have elevated risk in patients with hyperglycemia.
Saheed Ayodeji, Emily A. Teslow, Lisa A. Polin, Greg Dyson, Aliccia Bollig-Fischer, and Charlie Fehl. Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer. Cancer Cell International 2023;23:102.
Yimin Liu, Zachary M. Nelson, Ali Reda, and Charlie Fehl. Spatiotemporal Proximity Labeling Tools to Track GlcNAc Sugar-Modified Functional Protein Hubs during Cellular Signaling. ACS Chemical Biology 2022;17:2153.
Courtney A. Kon dor, Jaggaiah N. Gorantla, Garry D. Leonard, and Charlie Fehl. Synthesis and mammalian cell compatibility of light-released glycan precursors for controlled metabolic engineering. Bioorganic & Medicinal Chemical 2022;70:116918.
Charlie Fehl and John A. Hanover. Tools, Tactics, and Objectives to Interrogate Cellular Roles of O-GlcNAc in Disease. Nature Chemical Biology 2022;18:8-17.
Groenevelt, Jessica M.; Corey, Daniel J.; Fehl, Charlie. Chemical Synthesis and Biological Applications of O-GlcNAcylated Peptides and Proteins. ChemBioChem 2021;22:1854-70.
Josephson, Brian*; Fehl, Charlie*; Iseneggar, Patrick* [*equal contributors]; Nadal, Simon; Wright, Tom H.; Poh, Adeline W.J.; Bower, Ben J.; Giltrap, Andrew M.; Chen, Lifu; Batchelor-McAuley, Christopher; Roper, Grace; Arisa, Oluwatobi; Sap, Jeroen B.I.; Kawamura, Akane; Baldwin, Andrew; Mohammed, Shabaz; Compton, Richard G.; Gouverneur, Veronique; Davis, Benjamin. G. Mild, Light-Driven, Posttranslational Installation of Reactive Protein Side-Chains. Nature 2020;585: 530.
Yang, Min*; Fehl, Charlie* [*equal contributors]; Lees, Karen V.; Lim, Eng-Kiat; Offen, Wendy; Davies, Gideon J.; Bowles, Dianna J.; Roberts, Stephen J.; Davis, Benjamin G. Functional and informatics analysis enables glycosyltransferase activity prediction. Nature Chemical Biology 2018;14:1109.
Fehl, Charlie; Vogt, Caleb; Yadav, Rahul; Li, Kelin; Scott, Emily E.; Aubé, Jeffrey. Structure-based design of inhibitors with improved selectivity for steroidogenic cytochrome P450 17A1 over cytochrome P450 21A2. J. Med. Chem. 2018;61:4946.
Postdoc, 2018, University of Oxford - Chemical Biology
Ph.D. 2014, University of Kansas - Medicinal Chemistry
B.S. 2009, University of Michigan - Biochemistry